Article Summary: A recent study by Axon Relief found that 86% of migraine sufferers reported relief after using a CBD oil formulation for 30 days, based on the Headache Impact Test (Hit-6). Participants experienced an average reduction of 3.8 headache days, with chronic sufferers seeing a 33% decrease in headache frequency. Although clinical studies specifically on CBD for migraines are lacking, anecdotal evidence and preliminary research suggest CBD’s potential benefits, including anti-inflammatory properties. Axon’s survey highlights the need for more rigorous scientific research to validate CBD’s effectiveness as a migraine treatment.